KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma.

EBioMedicine · 2024-Dec · PMID 39631145

Panel C提取完成待 EXE 对齐验证

Progression Free Survival

Fig. 4 Progression-free survival stratified by CD8A gene expression in the discovery and validation cohorts, and CD8A/rituximab interaction analysis. A) TROG99.03 discovery cohort. B) AusESFL validation cohort. C) CanESFL validation cohort. D) TROG99. 03 discovery cohort stratified by rituximab use and CD8A gene expression.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分1.00
质量通过是
预期曲线2
实际曲线2
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0complete待验证22026-07-23T18:34:36+00:00